Moderate

Eosinophilic fasciitis

Shulman syndrome, peau d'orange fascia · Rheumatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

A scleroderma-like disorder with symmetrical inflammatory thickening of the deep fascia of the limbs, sparing the fingers and face, often following vigorous exertion. It presents with painful swelling then 'peau d'orange' induration and the characteristic 'groove sign', with peripheral eosinophilia.

Red flags

  • Rapidly progressive induration with joint contractures
  • Associated cytopenias or haematological malignancy
  • Features suggesting systemic sclerosis with internal organ involvement
  • Marked functional loss of a limb
  • Non-response to steroids (reconsider diagnosis)

Assessment

Differential diagnosis

  • Systemic sclerosis
  • Scleromyxoedema / scleroedema
  • Chronic graft-versus-host disease
  • Hypereosinophilic syndrome
  • Nephrogenic systemic fibrosis
  • Eosinophilia-myalgia syndrome

Investigations

  • FBC (peripheral eosinophilia) and CRP/ESR
  • Full-thickness skin-to-muscle biopsy (fascial thickening with inflammation/eosinophils)
  • MRI of affected limbs (fascial thickening and enhancement)
  • Serum aldolase and CK (variable)
  • ANA / scleroderma antibodies (usually negative, to exclude SSc)
  • Blood film and serum protein electrophoresis (exclude haematological association)

Management

  • Suspect in symmetrical limb induration with the groove sign after exertion, sparing hands/face
  • Confirm with MRI and full-thickness fascial biopsy
  • Check for peripheral eosinophilia and exclude haematological disorders
  • Exclude systemic sclerosis (absent Raynaud, nailfold changes and sclerodermatous antibodies)
  • Start corticosteroids as first-line, which usually improve induration
  • Add a steroid-sparing agent (methotrexate) for incomplete response or to reduce steroid exposure
  • Provide physiotherapy to maintain range of movement and prevent contractures
  • Monitor for relapse and residual fibrosis

Drugs & doses

Prednisolone — 0.5-1 mg/kg/day PO (up to 60 mg) with taper
Methylprednisolone — 500 mg-1 g IV OD x3 for severe/rapidly progressive disease
Methotrexate — 15-25 mg PO/SC once weekly with folic acid (steroid-sparing)
Mycophenolate mofetil — 1 g PO BD as alternative steroid-sparing agent

Disposition

Outpatient rheumatology management with steroids and physiotherapy; admission only for severe or diagnostically uncertain disease.

Complications & pitfalls

  • Joint contractures and functional disability
  • Carpal tunnel syndrome from fascial swelling
  • Associated haematological disorders (aplastic anaemia, myeloproliferative)
  • Residual fibrosis despite treatment

Exam pearls

  • The 'groove sign' (depression along superficial veins) and sparing of fingers/face distinguish it from systemic sclerosis
  • Raynaud and sclerodermatous nailfold changes are absent
  • Eosinophilia may be transient and is not required for diagnosis
  • Early steroids give the best functional outcome

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.